These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. French JA, Kanner AM, Bautista J, Abou-Khalil B, Browne T, Harden CL, Theodore WH, Bazil C, Stern J, Schachter SC, Bergen D, Hirtz D, Montouris GD, Nespeca M, Gidal B, Marks WJ, Turk WR, Fischer JH, Bourgeois B, Wilner A, Faught RE, Sachdeo RC, Beydoun A, Glauser TA, Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology, Quality Standards Subcommittee of the American Academy of Neurology, American Epilepsy Society. Neurology; 2004 Apr 27; 62(8):1261-73. PubMed ID: 15111660 [Abstract] [Full Text] [Related]
4. The new antiepileptic drugs: scientific review. LaRoche SM, Helmers SL. JAMA; 2004 Feb 04; 291(5):605-14. PubMed ID: 14762040 [Abstract] [Full Text] [Related]
11. The 'number needed to treat' with levetiracetam (LEV): comparison with the other new antiepileptic drugs (AEDs). van Rijckevorsel K, Boon PA. Seizure; 2002 Apr 04; 11 Suppl A():235-6. PubMed ID: 12185762 [No Abstract] [Full Text] [Related]
14. Efficacy and tolerability of the new antiepileptic drugs, I: Treatment of new-onset epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society. French JA, Kanner AM, Bautista J, Abou-Khalil B, Browne T, Harden CL, Theodore WH, Bazil C, Stern J, Schachter SC, Bergen D, Hirtz D, Montouris GD, Nespeca M, Gidal B, Marks WJ, Turk WR, Fischer JH, Bourgeois B, Wilner A, Faught RE, Sachdeo RC, Beydoun A, Glauser TA, American Academy of Neurology Therapeutics and Technology Assessment Subcommittee, American Academy of Neurology Quality Standards Subcommittee, American Epilepsy Society Quality Standards Subcommittee, American Epilepsy Society Therapeutics and Technology Assessment Subcommittee. Epilepsia; 2004 May 04; 45(5):401-9. PubMed ID: 15101821 [Abstract] [Full Text] [Related]
15. Newer anticonvulsants in the treatment of bipolar disorder. Yatham LN. J Clin Psychiatry; 2004 May 04; 65 Suppl 10():28-35. PubMed ID: 15242330 [Abstract] [Full Text] [Related]
17. New antiepileptic drug therapies. Bergin AM, Connolly M. Neurol Clin; 2002 Nov 04; 20(4):1163-82. PubMed ID: 12616686 [Abstract] [Full Text] [Related]
18. Overview of the safety of newer antiepileptic drugs. Shorvon S, Stefan H. Epilepsia; 1997 Nov 04; 38 Suppl 1():S45-51. PubMed ID: 9092960 [Abstract] [Full Text] [Related]
19. [The role of the neuromodulators in the preventive treatment of migraine]. Pascual-Gómez J. Rev Neurol; 1997 Nov 04; 49(1):25-32. PubMed ID: 19557697 [Abstract] [Full Text] [Related]
20. Novel anticonvulsant drugs. Stefan H, Feuerstein TJ. Pharmacol Ther; 2007 Jan 04; 113(1):165-83. PubMed ID: 17030393 [Abstract] [Full Text] [Related] Page: [Next] [New Search]